Biogen Inc.
BIIBNASDAQHealthcare● Active
$195.34
$-1.11(-0.57%)
Market Cap$28.8B
P/E Ratio—
52W High$205.97
52W Low$121.05
Biogen Inc. (BIIB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIIB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $9.81B | $9.68B | $9.84B | $10.17B | $10.98B |
| Cost of Revenue | $2.90B | $2.31B | $2.53B | $2.28B | $2.11B |
| Gross Profit | $6.91B | $7.37B | $7.30B | $7.90B | $8.87B |
| Gross Margin %(computed) | 70.47% | 76.12% | 74.24% | 77.61% | 80.79% |
| Operating Expenses | |||||
| R&D Expenses | $1.95B | $2.49B | $2.70B | $2.60B | $3.40B |
| G&A Expenses | $2.43B | $2.32B | $2.43B | $2.35B | $2.58B |
| Total Operating Expenses | $5.04B | $4.88B | $5.20B | $5.01B | $6.08B |
| Operating Income | $1.88B | $2.49B | $2.10B | $2.89B | $2.79B |
| Operating Margin %(computed) | 19.14% | 25.74% | 21.32% | 28.40% | 25.42% |
| Interest Income | $0.09B | $0.07B | $0.28B | $0.09B | $0.01B |
| Interest Expense | $0.25B | $0.25B | $0.25B | $0.25B | $0.25B |
| Income Before Tax | $1.40B | $1.91B | $1.30B | $3.59B | $1.78B |
| Income Tax Expense | $0.11B | $0.27B | $0.14B | $0.63B | $0.05B |
| Net Income | $1.29B | $1.63B | $1.16B | $3.05B | $1.56B |
| Net Margin %(computed) | 13.18% | 16.87% | 11.81% | 29.95% | 14.17% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $8.85 | $11.20 | $8.02 | $20.97 | $10.44 |
| Wtd Avg Shares | 0.15B | 0.15B | 0.14B | 0.15B | 0.15B |
| EBITDA | $3.10B | $3.00B | $2.38B | $3.54B | $3.92B |
| EBITDA Margin %(computed) | 31.60% | 30.96% | 24.17% | 34.77% | 35.73% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Biogen Inc. data
About Biogen Inc. (BIIB) Income Statement
Biogen Inc. (BIIB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BIIB reported revenue of $9.81B, gross profit of $6.91B (gross margin 70.47%), and net income of $1.29B — a net profit margin of 13.18%.
Frequently asked questions
BIIB · 4 questionsBiogen Inc. (BIIB) reported revenue of $9.81B for 2025, up 1.4% year-over-year.
BIIB revenueBIIB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08